Semaglutide has emerged as a novel treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to secrete more insulin and reducing glucagon https://kaleszxk462970.ampedpages.com/grasping-semaglutide-a-comprehensive-guide-62598042